Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
NCT04025840Phase 4Active, not recruiting
- Sponsor
- Peking University First Hospital
- Start
- Sep 2019
- Primary completion
- Oct 2024
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, ropivacaine hydrochloride liposomal suspension injection in pancreatic cancer (PC), sponsored by Peking University First Hospital. Started Sep 2019; status: active, not recruiting.
02
Drugs
dexamethasoneropivacaine hydrochloride liposomal suspension injection
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04025840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04025840.